Cargando…
Design and development of intraocular polymeric implant systems for long-term controlled-release of clindamycin phosphate for toxoplasmic retinochoroiditis
BACKGROUND: The release of the anti-toxoplasmosis drug, clindamycin phosphate, from intraocular implants of the biodegradable polymers poly (D, L-lactic acid) (PLA) and poly (D, L-lactide-co-glycolide) (PLGA) has been studied in vitro. MATERIALS AND METHODS: The preparation of the implants was perfo...
Autores principales: | Tamaddon, Lana, Mostafavi, S Abolfazl, Karkhane, Reza, Riazi-Esfahani, Mohammad, Dorkoosh, Farid Abedin, Rafiee-Tehrani, Morteza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333484/ https://www.ncbi.nlm.nih.gov/pubmed/25709997 http://dx.doi.org/10.4103/2277-9175.150426 |
Ejemplares similares
-
Thermoanalytical characterization of clindamycin-loaded intravitreal implants prepared by hot melt extrusion
por: Tamaddon, Lana, et al.
Publicado: (2015) -
Development, Characterizations and Biocompatibility Evaluations of Intravitreal Lipid Implants
por: Tamaddon, Lana, et al.
Publicado: (2014) -
Intravitreal Clindamycin as First-Line Therapy for Toxoplasmic Retinochoroiditis: A Case Series
por: Verma, Lalit, et al.
Publicado: (2020) -
A prospective randomized trial of azithromycin versus trimethoprim/sulfamethoxazole in treatment of toxoplasmic retinochoroiditis
por: Lashay, Alireza, et al.
Publicado: (2016) -
Interleukin-1 gene polymorphisms and toxoplasmic retinochoroiditis
por: Cordeiro, Cynthia A., et al.
Publicado: (2008)